Abstract
Cloacal anomalies (persistent cloaca) represent the most severe form of anorectal malformations in girls where the rectum, urethra, and vagina remain fused together inside the pelvis and drain into a single common perineal orifice. Infants with cloacal anomalies often succumb to poor lung development due to oligohydramnios. Cloacal anomaly in discordant monozygotic twins has rarely been reported in the literature. In this review, we present the first case of persistent cloaca and complete urinary tract obstruction in discordant monoamniotic twins.
References
1.
Chitrit Y, Vuillard E, Khung S, Belarbi N, Guimiot F, Muller F, et al: Cloaca in -discordant monoamniotic twins: prenatal diagnosis and consequence for fetal lung development. AJP Rep 2014; 4: 33–36.
2.
Fernando MA, Creighton SM, Wood D: The long-term management and outcomes of cloacal anomalies. Pediatr Nephrol 2015; 30: 759–765.
3.
Levitt MA, Pena A: Cloacal malformations: lessons learned from 490 cases. Semin Pediatr Surg 2010; 19: 128–138.
4.
Meyer SR, Smith KM, Ravish IR, Saltzman DA, Shukla AR: Complex cloacal anomaly in discordant monozygotic twins. Urology 2009; 73: 532–534.
5.
Warne SA, Hiorns MP, Curry J, Mushtaq I: Understanding cloacal anomalies. Arch Dis Child 2011; 96: 1072–1076.
6.
Haeri S: Fetal lower urinary tract obstruction (LUTO): a practical review for providers. Matern Health Neonatol Perinatol 2015; 1: 26.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.